Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,410 public trials 2,002 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Completed

PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk

NCT01879189

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Edward S. Cooper Internal Medicine Philadelphia, Pennsylvania, United States
  • Family Medicine St. Leonard's Court Philadelphia, Pennsylvania, United States
  • Family Medicine Philadelphia, Pennsylvania, United States
  • Helen O. Dickens Center for Women's Health Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients

NCT01764022

Conditions
Breast Diseases, Breast Neoplasms, Human Epithelial Receptor (HER)-2 Positive Breast Cancer, +4 more
Locations
  • Brest Region Clinical Oncology Dispensary Brest, Belarus
  • Grodno Regional Hospital Grodno, Belarus
  • Gomel Region Clinical Oncology Dispensary Homyel, Belarus
  • Vitebsk State Medical University of Order of Peoples' Friendship Vitebsk, Belarus
View all 36 locations
View Trial Details
Completed

hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

NCT02960594

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +53 more
Locations
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer

NCT02481050

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Facility #1 Denver, Colorado, United States
  • Facility #1 Columbia, Maryland, United States
  • Facility #1 Omaha, Nebraska, United States
  • Facility #1 Albany, New York, United States
View Trial Details

Related conditions